Correlation Between Pasithea Therapeutics and Paragon 28

Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and Paragon 28 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and Paragon 28 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pasithea Therapeutics Corp and Paragon 28, you can compare the effects of market volatilities on Pasithea Therapeutics and Paragon 28 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of Paragon 28. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and Paragon 28.

Diversification Opportunities for Pasithea Therapeutics and Paragon 28

-0.04

Correlation Coefficient

Pasithea Therapeutics  Paragon 28

Good diversification

The 3 months correlation between Pasithea and Paragon is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and Paragon 28 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Paragon 28 and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with Paragon 28. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Paragon 28 has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and Paragon 28 go up and down completely randomly.

Pair Corralation between Pasithea Therapeutics and Paragon 28

Assuming the 90 days horizon Pasithea Therapeutics Corp is expected to generate 11.46 times more return on investment than Paragon 28. However, Pasithea Therapeutics is 11.46 times more volatile than Paragon 28. It trades about 0.07 of its potential returns per unit of risk. Paragon 28 is currently generating about 0.24 per unit of risk. If you would invest  2.19  in Pasithea Therapeutics Corp on December 22, 2024 and sell it today you would lose (0.19) from holding Pasithea Therapeutics Corp or give up 8.68% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	49.18%
Values	Daily Returns

Pasithea Therapeutics Corp  vs.  Paragon 28

Pasithea Therapeutics

Risk-Adjusted Performance

Modest

Over the last 90 days Pasithea Therapeutics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly weak basic indicators, Pasithea Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Paragon 28

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Paragon 28 are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. Despite somewhat fragile basic indicators, Paragon 28 sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Pasithea Therapeutics and Paragon 28

The main advantage of trading using opposite Pasithea Therapeutics and Paragon 28 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, Paragon 28 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Paragon 28 will offset losses from the drop in Paragon 28's long position.

The idea behind Pasithea Therapeutics Corp and Paragon 28 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.